| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | UNC0321 | CTRPv2 | pan-cancer | AAC | 0.25 | 3e-12 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | 0.29 | 2e-09 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | -0.12 | 5e-06 |
| mRNA | IC-87114 | CTRPv2 | pan-cancer | AAC | 0.16 | 9e-06 |
| mRNA | HC-067047 | CTRPv2 | pan-cancer | AAC | 0.16 | 3e-05 |
| mRNA | CAY10594 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0003 |
| mRNA | GSK4112 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0003 |
| mRNA | TAE684 | GDSC1000 | pan-cancer | AAC | -0.19 | 0.0004 |
| mRNA | BRD-K55473186 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.0006 |
| mRNA | decitabine:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.094 | 0.0008 |